Development of Crizotinib, a Rationally Designed Tyrosine Kinase Inhibitor for Non-Small Cell Lung Cancer
International Journal of Cancer - United States
doi 10.1002/ijc.30533
Full Text
Open PDFAbstract
Available in full text
Date
January 20, 2017
Authors
Publisher
Wiley